Strategy& Insider Titelbild

Strategy& Insider

Strategy& Insider

Von: Thomas Solbach Ghioia Irritier Jan-Philipp Loch
Jetzt kostenlos hören, ohne Abo

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.PwC Strategy& (Germany) GmbH Hygiene & gesundes Leben Management & Leadership Ökonomie
  • Strategy& Insider Episode 48 - Rewriting medicine with CRISPR and genome editing
    Jul 22 2026
    What if curing a disease took a single treatment instead of a lifetime of pills, and the same technology could help cool the planet? In this episode, Dr. Bradley Ringeisen, Executive Director of the Innovative Genomics Institute (IGI) at UC Berkeley, takes us inside the CRISPR revolution. From the first FDA-approved sickle cell therapy to a custom cure that saved a baby's life in Philadelphia, to rice engineered to emit 60% less methane, Brad reveals how genome editing is reshaping medicine, climate, and food security alike. We dig into the science, the make-or-break "delivery" challenge, and the IGI's "CRISPR Commons" initiative, a bold plan to make genome editing equitably accessible worldwide.
    Mehr anzeigen Weniger anzeigen
    42 Min.
  • Strategy& Insider Episode 47 - Unlocking personalized health through genomics
    Jun 24 2026
    In this episode, Michel Mommejat, President of A.D.A.M. Innovations, shares how genomics and AI are transforming healthcare from reactive treatment to preventative wellcare. Recorded in Tokyo, this conversation explores what your DNA can reveal as a biological blueprint, why Japan serves as the world's laboratory for healthy aging, and how combining genetic data with biomarkers and lifestyle information creates a dynamic, personalized health ecosystem. Michel also discusses the ethical frameworks needed to protect the most sensitive data that exists, the concept of Artificial General Gene Intelligence, and practical applications like pharmacogenomics that are already changing how we think about medication. Tune in for a visionary conversation on the future of health and longevity.
    Mehr anzeigen Weniger anzeigen
    45 Min.
  • Strategy& Insider Episode 46 - Detecting disease in seconds of speech
    May 20 2026
    Lara Gervaise and Edoardo Giudice are the co-founders of Virtuosis AI, a start-up pioneering voice biomarker technology. In this episode, they reveal how just 30 seconds of speech can be analyzed to screen for up to 25 health conditions – from Parkinson's and Alzheimer's to depression, anxiety, and cardiometabolic disorders. They share how a chance meeting before generative AI even existed sparked a conviction that voice and AI could transform preventive care at scale. The conversation covers their path from wellness tool to CE-certified medical device, the ethical safeguards behind their workplace integration, what it takes to build health AI in Europe's regulatory environment, and their ultimate vision: a future where monitoring your voice is as routine as tracking your steps, seamlessly embedded into everyday life.
    Mehr anzeigen Weniger anzeigen
    47 Min.
adbl_web_anon_alc_button_suppression_t1
Noch keine Rezensionen vorhanden